{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifc2ybjbcktbvsfxqmhssnpa3wvaikhqokfeqzjg6k7qz434udtoe",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mf5awtj3ixq2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihcw3xrsyasmj5vmoyo6hzwc3sn6mqage575tmtgvsyo2le75tgfe"
    },
    "mimeType": "image/jpeg",
    "size": 79566
  },
  "path": "/2026/02/18/fda-moderna-reverse-course-flu-vaccine/?utm_campaign=rss",
  "publishedAt": "2026-02-18T12:29:42.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Breaking News",
    "biotechnology",
    "Moderna",
    "Pharmaceuticals",
    "STAT+",
    "Vaccines"
  ],
  "textContent": "The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.",
  "title": "STAT+: FDA reverses course, agrees to review Moderna’s flu vaccine",
  "updatedAt": "2026-02-18T14:02:28.000Z"
}